|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:TLK1-CAT (FusionGDB2 ID:90502) |
Fusion Gene Summary for TLK1-CAT |
Fusion gene summary |
Fusion gene information | Fusion gene name: TLK1-CAT | Fusion gene ID: 90502 | Hgene | Tgene | Gene symbol | TLK1 | CAT | Gene ID | 9874 | 10249 |
Gene name | tousled like kinase 1 | glycine-N-acyltransferase | |
Synonyms | PKU-beta | ACGNAT|CAT|GAT | |
Cytomap | 2q31.1 | 11q12.1 | |
Type of gene | protein-coding | protein-coding | |
Description | serine/threonine-protein kinase tousled-like 1SNARE protein kinase SNAKserine threonine protein kinase | glycine N-acyltransferaseAAcHRP-1(CLP)acyl-CoA:glycine N-acyltransferasearalkyl acyl-CoA N-acyltransferasearalkyl acyl-CoA:amino acid N-acyltransferasearalkyl-CoA N-acyltransferasebenzoyl-coenzyme A:glycine N-acyltransferaseepididymis secretory sp | |
Modification date | 20200329 | 20200313 | |
UniProtAcc | . | Q6ZRH7 | |
Ensembl transtripts involved in fusion gene | ENST00000360843, ENST00000431350, ENST00000442919, ENST00000521943, ENST00000434911, ENST00000486857, | ENST00000241052, ENST00000534710, | |
Fusion gene scores | * DoF score | 13 X 15 X 6=1170 | 14 X 11 X 8=1232 |
# samples | 18 | 18 | |
** MAII score | log2(18/1170*10)=-2.70043971814109 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(18/1232*10)=-2.77493344436523 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: TLK1 [Title/Abstract] AND CAT [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | TLK1(171974249)-CAT(34470739), # samples:3 | ||
Anticipated loss of major functional domain due to fusion event. | TLK1-CAT seems lost the major protein functional domain in Hgene partner, which is a kinase due to the frame-shifted ORF. TLK1-CAT seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. TLK1-CAT seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. TLK1-CAT seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. TLK1-CAT seems lost the major protein functional domain in Tgene partner, which is a tumor suppressor due to the frame-shifted ORF. TLK1-CAT seems lost the major protein functional domain in Tgene partner, which is a cell metabolism gene due to the frame-shifted ORF. TLK1-CAT seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TLK1 | GO:0001672 | regulation of chromatin assembly or disassembly | 12660173 |
Hgene | TLK1 | GO:0006468 | protein phosphorylation | 12660173 |
Hgene | TLK1 | GO:0006886 | intracellular protein transport | 10588641 |
Hgene | TLK1 | GO:0035556 | intracellular signal transduction | 12660173 |
Tgene | CAT | GO:0006544 | glycine metabolic process | 22475485 |
Tgene | CAT | GO:1901787 | benzoyl-CoA metabolic process | 22475485 |
Fusion gene breakpoints across TLK1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across CAT (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-EW-A1P7-01A | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
ChimerDB4 | BRCA | TCGA-EW-A1P7-01A | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
ChimerDB4 | BRCA | TCGA-EW-A1P7-01A | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
Top |
Fusion Gene ORF analysis for TLK1-CAT |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000360843 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
5CDS-intron | ENST00000360843 | ENST00000534710 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
In-frame | ENST00000431350 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
5CDS-intron | ENST00000431350 | ENST00000534710 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
In-frame | ENST00000442919 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
5CDS-intron | ENST00000442919 | ENST00000534710 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
Frame-shift | ENST00000521943 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
5CDS-intron | ENST00000521943 | ENST00000534710 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
intron-3CDS | ENST00000434911 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
intron-intron | ENST00000434911 | ENST00000534710 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
intron-3CDS | ENST00000486857 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
intron-intron | ENST00000486857 | ENST00000534710 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000360843 | TLK1 | chr2 | 171974249 | - | ENST00000241052 | CAT | chr11 | 34470739 | + | 2810 | 663 | 402 | 2180 | 592 |
ENST00000431350 | TLK1 | chr2 | 171974249 | - | ENST00000241052 | CAT | chr11 | 34470739 | + | 2810 | 663 | 402 | 2180 | 592 |
ENST00000442919 | TLK1 | chr2 | 171974249 | - | ENST00000241052 | CAT | chr11 | 34470739 | + | 2877 | 730 | 469 | 2247 | 592 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000360843 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + | 0.000790509 | 0.9992094 |
ENST00000431350 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + | 0.000790509 | 0.9992094 |
ENST00000442919 | ENST00000241052 | TLK1 | chr2 | 171974249 | - | CAT | chr11 | 34470739 | + | 0.000866267 | 0.99913377 |
Top |
Fusion Genomic Features for TLK1-CAT |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
TLK1 | chr2 | 171974248 | - | CAT | chr11 | 34470738 | + | 3.17E-07 | 0.99999964 |
TLK1 | chr2 | 171974248 | - | CAT | chr11 | 34470738 | + | 3.17E-07 | 0.99999964 |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TLK1-CAT |
Go to FGviewer for the breakpoints of chr2:171974249-chr11:34470739 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | CAT |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Probably involved in sperm cell hyperactivation via its association with CATSPER1. Sperm cell hyperactivation is needed for sperm motility which is essential late in the preparation of sperm for fertilization. {ECO:0000250|UniProtKB:C6KI89}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000360843 | - | 2 | 22 | 230_281 | 86.0 | 788.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000360843 | - | 2 | 22 | 397_445 | 86.0 | 788.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000431350 | - | 2 | 21 | 230_281 | 86.0 | 767.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000431350 | - | 2 | 21 | 397_445 | 86.0 | 767.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000434911 | - | 1 | 19 | 230_281 | 0 | 671.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000434911 | - | 1 | 19 | 397_445 | 0 | 671.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000442919 | - | 2 | 21 | 230_281 | 38.0 | 719.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000442919 | - | 2 | 21 | 397_445 | 38.0 | 719.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000521943 | - | 2 | 21 | 230_281 | 38.0 | 719.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000521943 | - | 2 | 21 | 397_445 | 38.0 | 719.0 | Coiled coil | Ontology_term=ECO:0000255 |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000360843 | - | 2 | 22 | 456_734 | 86.0 | 788.0 | Domain | Protein kinase |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000431350 | - | 2 | 21 | 456_734 | 86.0 | 767.0 | Domain | Protein kinase |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000434911 | - | 1 | 19 | 456_734 | 0 | 671.0 | Domain | Protein kinase |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000442919 | - | 2 | 21 | 456_734 | 38.0 | 719.0 | Domain | Protein kinase |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000521943 | - | 2 | 21 | 456_734 | 38.0 | 719.0 | Domain | Protein kinase |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000360843 | - | 2 | 22 | 462_470 | 86.0 | 788.0 | Nucleotide binding | ATP |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000431350 | - | 2 | 21 | 462_470 | 86.0 | 767.0 | Nucleotide binding | ATP |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000434911 | - | 1 | 19 | 462_470 | 0 | 671.0 | Nucleotide binding | ATP |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000442919 | - | 2 | 21 | 462_470 | 38.0 | 719.0 | Nucleotide binding | ATP |
Hgene | TLK1 | chr2:171974249 | chr11:34470739 | ENST00000521943 | - | 2 | 21 | 462_470 | 38.0 | 719.0 | Nucleotide binding | ATP |
Top |
Fusion Gene Sequence for TLK1-CAT |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000360843_ENST00000241052_TCGA-EW-A1P7-01A_TLK1_chr2_171974249_-_CAT_chr11_34470739_length(transcript)=2810nt_BP=663nt GACGCCGGGGGCCGACGCACTGCAGAGGTGCCGGCAGGTTCCGCCCGCGGAAGTGTCCTCGGCCGGCGCAGCCCGCGCTCCGCCCGCGCT CCGACCCCGGCCCGGCTGGCACCCCCTCGACGCCTCCGCCGCCGCGCTCCTTTCCTCCTCCTCTCCTCTGGCGCGCCCGCTCGCTCCCTC GCTTCTCCCCCTTTCCCTCCTCCCTGTCCCCTCTCCTTCCCTCACCTCTTTCCTCCCCACCTCCCCTCTTCTCGGTTTCCTCCCCCATCC CCTTGACTCTCCCCTCCCAGCCCTCGCTCTCTCGCTCGCCCTCAGCGCGGCCCCCGCCATGACGGAGGCGGGTGCCGGTGCCGTTGCCGC CGCTGCCGTCGCAGGGGGGGAGTCGGGTTCCCAGAAAGTAGCTTGATGAGTGTCCAAAGTAGCAGTGGAAGTTTGGAGGGGCCGCCATCT TGGTCCCAGCTCTCCACGTCTCCAACCCCGGGCTCGGCGGCGGCGGCCAGGTCCCTGCTGAATCACACGCCGCCATCCGGGAGGCCCAGG GAAGGTGCAATGGATGAGCTTCATAGTCTGGATCCAAGAAGGCAAGAGTTATTGGAAGCTAGATTTACTGGAGTTGCAAGTGGGAGCACT GGAAGTACGGGCAGTTGCAGTGTTGGAGCTAAAAAAGCTGATGTCCTGACCACTGGAGCTGGTAACCCAGTAGGAGACAAACTTAATGTT ATTACAGTAGGGCCCCGTGGGCCCCTTCTTGTTCAGGATGTGGTTTTCACTGATGAAATGGCTCATTTTGACCGAGAGAGAATTCCTGAG AGAGTTGTGCATGCTAAAGGAGCAGGGGCCTTTGGCTACTTTGAGGTCACACATGACATTACCAAATACTCCAAGGCAAAGGTATTTGAG CATATTGGAAAGAAGACTCCCATCGCAGTTCGGTTCTCCACTGTTGCTGGAGAATCGGGTTCAGCTGACACAGTTCGGGACCCTCGTGGG TTTGCAGTGAAATTTTACACAGAAGATGGTAACTGGGATCTCGTTGGAAATAACACCCCCATTTTCTTCATCAGGGATCCCATATTGTTT CCATCTTTTATCCACAGCCAAAAGAGAAATCCTCAGACACATCTGAAGGATCCGGACATGGTCTGGGACTTCTGGAGCCTACGTCCTGAG TCTCTGCATCAGGTTTCTTTCTTGTTCAGTGATCGGGGGATTCCAGATGGACATCGCCACATGAATGGATATGGATCACATACTTTCAAG CTGGTTAATGCAAATGGGGAGGCAGTTTATTGCAAATTCCATTATAAGACTGACCAGGGCATCAAAAACCTTTCTGTTGAAGATGCGGCG AGACTTTCCCAGGAAGATCCTGACTATGGCATCCGGGATCTTTTTAACGCCATTGCCACAGGAAAGTACCCCTCCTGGACTTTTTACATC CAGGTCATGACATTTAATCAGGCAGAAACTTTTCCATTTAATCCATTCGATCTCACCAAGGTTTGGCCTCACAAGGACTACCCTCTCATC CCAGTTGGTAAACTGGTCTTAAACCGGAATCCAGTTAATTACTTTGCTGAGGTTGAACAGATAGCCTTCGACCCAAGCAACATGCCACCT GGCATTGAGGCCAGTCCTGACAAAATGCTTCAGGGCCGCCTTTTTGCCTATCCTGACACTCACCGCCATCGCCTGGGACCCAATTATCTT CATATACCTGTGAACTGTCCCTACCGTGCTCGAGTGGCCAACTACCAGCGTGACGGCCCGATGTGCATGCAGGACAATCAGGGTGGTGCT CCAAATTACTACCCCAACAGCTTTGGTGCTCCGGAACAACAGCCTTCTGCCCTGGAGCACAGCATCCAATATTCTGGAGAAGTGCGGAGA TTCAACACTGCCAATGATGATAACGTTACTCAGGTGCGGGCATTCTATGTGAACGTGCTGAATGAGGAACAGAGGAAACGTCTGTGTGAG AACATTGCCGGCCACCTGAAGGATGCACAAATTTTCATCCAGAAGAAAGCGGTCAAGAACTTCACTGAGGTCCACCCTGACTACGGGAGC CACATCCAGGCTCTTCTGGACAAGTACAATGCTGAGAAGCCTAAGAATGCGATTCACACCTTTGTGCAGTCCGGATCTCACTTGGCGGCA AGGGAGAAGGCAAATCTGTGAGGCCGGGGCCCTGCACCTGTGCAGCGAAGCTTAGCGTTCATCCGTGTAACCCGCTCATCACTGGATGAA GATTCTCCTGTGCTAGATGTGCAAATGCAAGCTAGTGGCTTCAAAATAGAGAATCCCACTTTCTATAGCAGATTGTGTAACAATTTTAAT GCTATTTCCCCAGGGGAAAATGAAGGTTAGGATTTAACAGTCATTTAAAAAAAAAATTTGTTTTGACGGATGATTGGATTATTCATTTAA AATGATTAGAAGGCAAGTTTCTAGCTAGAAATATGATTTTATTTGACAAAATTTGTTGAAATTATGTATGTTTACATATCACCTCATGGC CTATTATATTAAAATATGGCTATAAATATATAAAAAGAAAAGATAAAGATGATCTACTCAGAAATTTTTATTTTTCTAAGGTTCTCATAG GAAAAGTACATTTAATACAGCAGTGTCATCAGAAGATAACTTGAGCACCGTCATGGCTTAATGTTTATTCCTGATAATAATTGATCAAAT TCATTTTTTTCACTGGAGTTACATTAATGTTAATTCAGCACTGATTTCACAACAGATCAATTTGTAATTGCTTACATTTTTACAATAAAT >In-frame_ENST00000360843_ENST00000241052_TCGA-EW-A1P7-01A_TLK1_chr2_171974249_-_CAT_chr11_34470739_length(amino acids)=592AA_start in transcript=402_stop in transcript=2180 MMSVQSSSGSLEGPPSWSQLSTSPTPGSAAAARSLLNHTPPSGRPREGAMDELHSLDPRRQELLEARFTGVASGSTGSTGSCSVGAKKAD VLTTGAGNPVGDKLNVITVGPRGPLLVQDVVFTDEMAHFDRERIPERVVHAKGAGAFGYFEVTHDITKYSKAKVFEHIGKKTPIAVRFST VAGESGSADTVRDPRGFAVKFYTEDGNWDLVGNNTPIFFIRDPILFPSFIHSQKRNPQTHLKDPDMVWDFWSLRPESLHQVSFLFSDRGI PDGHRHMNGYGSHTFKLVNANGEAVYCKFHYKTDQGIKNLSVEDAARLSQEDPDYGIRDLFNAIATGKYPSWTFYIQVMTFNQAETFPFN PFDLTKVWPHKDYPLIPVGKLVLNRNPVNYFAEVEQIAFDPSNMPPGIEASPDKMLQGRLFAYPDTHRHRLGPNYLHIPVNCPYRARVAN YQRDGPMCMQDNQGGAPNYYPNSFGAPEQQPSALEHSIQYSGEVRRFNTANDDNVTQVRAFYVNVLNEEQRKRLCENIAGHLKDAQIFIQ -------------------------------------------------------------- >In-frame_ENST00000431350_ENST00000241052_TCGA-EW-A1P7-01A_TLK1_chr2_171974249_-_CAT_chr11_34470739_length(transcript)=2810nt_BP=663nt GACGCCGGGGGCCGACGCACTGCAGAGGTGCCGGCAGGTTCCGCCCGCGGAAGTGTCCTCGGCCGGCGCAGCCCGCGCTCCGCCCGCGCT CCGACCCCGGCCCGGCTGGCACCCCCTCGACGCCTCCGCCGCCGCGCTCCTTTCCTCCTCCTCTCCTCTGGCGCGCCCGCTCGCTCCCTC GCTTCTCCCCCTTTCCCTCCTCCCTGTCCCCTCTCCTTCCCTCACCTCTTTCCTCCCCACCTCCCCTCTTCTCGGTTTCCTCCCCCATCC CCTTGACTCTCCCCTCCCAGCCCTCGCTCTCTCGCTCGCCCTCAGCGCGGCCCCCGCCATGACGGAGGCGGGTGCCGGTGCCGTTGCCGC CGCTGCCGTCGCAGGGGGGGAGTCGGGTTCCCAGAAAGTAGCTTGATGAGTGTCCAAAGTAGCAGTGGAAGTTTGGAGGGGCCGCCATCT TGGTCCCAGCTCTCCACGTCTCCAACCCCGGGCTCGGCGGCGGCGGCCAGGTCCCTGCTGAATCACACGCCGCCATCCGGGAGGCCCAGG GAAGGTGCAATGGATGAGCTTCATAGTCTGGATCCAAGAAGGCAAGAGTTATTGGAAGCTAGATTTACTGGAGTTGCAAGTGGGAGCACT GGAAGTACGGGCAGTTGCAGTGTTGGAGCTAAAAAAGCTGATGTCCTGACCACTGGAGCTGGTAACCCAGTAGGAGACAAACTTAATGTT ATTACAGTAGGGCCCCGTGGGCCCCTTCTTGTTCAGGATGTGGTTTTCACTGATGAAATGGCTCATTTTGACCGAGAGAGAATTCCTGAG AGAGTTGTGCATGCTAAAGGAGCAGGGGCCTTTGGCTACTTTGAGGTCACACATGACATTACCAAATACTCCAAGGCAAAGGTATTTGAG CATATTGGAAAGAAGACTCCCATCGCAGTTCGGTTCTCCACTGTTGCTGGAGAATCGGGTTCAGCTGACACAGTTCGGGACCCTCGTGGG TTTGCAGTGAAATTTTACACAGAAGATGGTAACTGGGATCTCGTTGGAAATAACACCCCCATTTTCTTCATCAGGGATCCCATATTGTTT CCATCTTTTATCCACAGCCAAAAGAGAAATCCTCAGACACATCTGAAGGATCCGGACATGGTCTGGGACTTCTGGAGCCTACGTCCTGAG TCTCTGCATCAGGTTTCTTTCTTGTTCAGTGATCGGGGGATTCCAGATGGACATCGCCACATGAATGGATATGGATCACATACTTTCAAG CTGGTTAATGCAAATGGGGAGGCAGTTTATTGCAAATTCCATTATAAGACTGACCAGGGCATCAAAAACCTTTCTGTTGAAGATGCGGCG AGACTTTCCCAGGAAGATCCTGACTATGGCATCCGGGATCTTTTTAACGCCATTGCCACAGGAAAGTACCCCTCCTGGACTTTTTACATC CAGGTCATGACATTTAATCAGGCAGAAACTTTTCCATTTAATCCATTCGATCTCACCAAGGTTTGGCCTCACAAGGACTACCCTCTCATC CCAGTTGGTAAACTGGTCTTAAACCGGAATCCAGTTAATTACTTTGCTGAGGTTGAACAGATAGCCTTCGACCCAAGCAACATGCCACCT GGCATTGAGGCCAGTCCTGACAAAATGCTTCAGGGCCGCCTTTTTGCCTATCCTGACACTCACCGCCATCGCCTGGGACCCAATTATCTT CATATACCTGTGAACTGTCCCTACCGTGCTCGAGTGGCCAACTACCAGCGTGACGGCCCGATGTGCATGCAGGACAATCAGGGTGGTGCT CCAAATTACTACCCCAACAGCTTTGGTGCTCCGGAACAACAGCCTTCTGCCCTGGAGCACAGCATCCAATATTCTGGAGAAGTGCGGAGA TTCAACACTGCCAATGATGATAACGTTACTCAGGTGCGGGCATTCTATGTGAACGTGCTGAATGAGGAACAGAGGAAACGTCTGTGTGAG AACATTGCCGGCCACCTGAAGGATGCACAAATTTTCATCCAGAAGAAAGCGGTCAAGAACTTCACTGAGGTCCACCCTGACTACGGGAGC CACATCCAGGCTCTTCTGGACAAGTACAATGCTGAGAAGCCTAAGAATGCGATTCACACCTTTGTGCAGTCCGGATCTCACTTGGCGGCA AGGGAGAAGGCAAATCTGTGAGGCCGGGGCCCTGCACCTGTGCAGCGAAGCTTAGCGTTCATCCGTGTAACCCGCTCATCACTGGATGAA GATTCTCCTGTGCTAGATGTGCAAATGCAAGCTAGTGGCTTCAAAATAGAGAATCCCACTTTCTATAGCAGATTGTGTAACAATTTTAAT GCTATTTCCCCAGGGGAAAATGAAGGTTAGGATTTAACAGTCATTTAAAAAAAAAATTTGTTTTGACGGATGATTGGATTATTCATTTAA AATGATTAGAAGGCAAGTTTCTAGCTAGAAATATGATTTTATTTGACAAAATTTGTTGAAATTATGTATGTTTACATATCACCTCATGGC CTATTATATTAAAATATGGCTATAAATATATAAAAAGAAAAGATAAAGATGATCTACTCAGAAATTTTTATTTTTCTAAGGTTCTCATAG GAAAAGTACATTTAATACAGCAGTGTCATCAGAAGATAACTTGAGCACCGTCATGGCTTAATGTTTATTCCTGATAATAATTGATCAAAT TCATTTTTTTCACTGGAGTTACATTAATGTTAATTCAGCACTGATTTCACAACAGATCAATTTGTAATTGCTTACATTTTTACAATAAAT >In-frame_ENST00000431350_ENST00000241052_TCGA-EW-A1P7-01A_TLK1_chr2_171974249_-_CAT_chr11_34470739_length(amino acids)=592AA_start in transcript=402_stop in transcript=2180 MMSVQSSSGSLEGPPSWSQLSTSPTPGSAAAARSLLNHTPPSGRPREGAMDELHSLDPRRQELLEARFTGVASGSTGSTGSCSVGAKKAD VLTTGAGNPVGDKLNVITVGPRGPLLVQDVVFTDEMAHFDRERIPERVVHAKGAGAFGYFEVTHDITKYSKAKVFEHIGKKTPIAVRFST VAGESGSADTVRDPRGFAVKFYTEDGNWDLVGNNTPIFFIRDPILFPSFIHSQKRNPQTHLKDPDMVWDFWSLRPESLHQVSFLFSDRGI PDGHRHMNGYGSHTFKLVNANGEAVYCKFHYKTDQGIKNLSVEDAARLSQEDPDYGIRDLFNAIATGKYPSWTFYIQVMTFNQAETFPFN PFDLTKVWPHKDYPLIPVGKLVLNRNPVNYFAEVEQIAFDPSNMPPGIEASPDKMLQGRLFAYPDTHRHRLGPNYLHIPVNCPYRARVAN YQRDGPMCMQDNQGGAPNYYPNSFGAPEQQPSALEHSIQYSGEVRRFNTANDDNVTQVRAFYVNVLNEEQRKRLCENIAGHLKDAQIFIQ -------------------------------------------------------------- >In-frame_ENST00000442919_ENST00000241052_TCGA-EW-A1P7-01A_TLK1_chr2_171974249_-_CAT_chr11_34470739_length(transcript)=2877nt_BP=730nt AACTGATGCAGAGGTTACCCCACCGCCTCAGCCGCCACCCACAGCCCGCCGCCGCCGCCTCCCGGGCGACGCCGGGGGCCGACGCACTGC AGAGGTGCCGGCAGGTTCCGCCCGCGGAAGTGTCCTCGGCCGGCGCAGCCCGCGCTCCGCCCGCGCTCCGACCCCGGCCCGGCTGGCACC CCCTCGACGCCTCCGCCGCCGCGCTCCTTTCCTCCTCCTCTCCTCTGGCGCGCCCGCTCGCTCCCTCGCTTCTCCCCCTTTCCCTCCTCC CTGTCCCCTCTCCTTCCCTCACCTCTTTCCTCCCCACCTCCCCTCTTCTCGGTTTCCTCCCCCATCCCCTTGACTCTCCCCTCCCAGCCC TCGCTCTCTCGCTCGCCCTCAGCGCGGCCCCCGCCATGACGGAGGCGGGTGCCGGTGCCGTTGCCGCCGCTGCCGTCGCAGGGGGGGAGT CGGGTTCCCAGAAAGTAGCTTGATGAGTGTCCAAAGTAGCAGTGGAAGTTTGGAGGGGCCGCCATCTTGGTCCCAGCTCTCCACGTCTCC AACCCCGGGCTCGGCGGCGGCGGCCAGGTCCCTGCTGAATCACACGCCGCCATCCGGGAGGCCCAGGGAAGGTGCAATGGATGAGCTTCA TAGTCTGGATCCAAGAAGGCAAGAGTTATTGGAAGCTAGATTTACTGGAGTTGCAAGTGGGAGCACTGGAAGTACGGGCAGTTGCAGTGT TGGAGCTAAAAAAGCTGATGTCCTGACCACTGGAGCTGGTAACCCAGTAGGAGACAAACTTAATGTTATTACAGTAGGGCCCCGTGGGCC CCTTCTTGTTCAGGATGTGGTTTTCACTGATGAAATGGCTCATTTTGACCGAGAGAGAATTCCTGAGAGAGTTGTGCATGCTAAAGGAGC AGGGGCCTTTGGCTACTTTGAGGTCACACATGACATTACCAAATACTCCAAGGCAAAGGTATTTGAGCATATTGGAAAGAAGACTCCCAT CGCAGTTCGGTTCTCCACTGTTGCTGGAGAATCGGGTTCAGCTGACACAGTTCGGGACCCTCGTGGGTTTGCAGTGAAATTTTACACAGA AGATGGTAACTGGGATCTCGTTGGAAATAACACCCCCATTTTCTTCATCAGGGATCCCATATTGTTTCCATCTTTTATCCACAGCCAAAA GAGAAATCCTCAGACACATCTGAAGGATCCGGACATGGTCTGGGACTTCTGGAGCCTACGTCCTGAGTCTCTGCATCAGGTTTCTTTCTT GTTCAGTGATCGGGGGATTCCAGATGGACATCGCCACATGAATGGATATGGATCACATACTTTCAAGCTGGTTAATGCAAATGGGGAGGC AGTTTATTGCAAATTCCATTATAAGACTGACCAGGGCATCAAAAACCTTTCTGTTGAAGATGCGGCGAGACTTTCCCAGGAAGATCCTGA CTATGGCATCCGGGATCTTTTTAACGCCATTGCCACAGGAAAGTACCCCTCCTGGACTTTTTACATCCAGGTCATGACATTTAATCAGGC AGAAACTTTTCCATTTAATCCATTCGATCTCACCAAGGTTTGGCCTCACAAGGACTACCCTCTCATCCCAGTTGGTAAACTGGTCTTAAA CCGGAATCCAGTTAATTACTTTGCTGAGGTTGAACAGATAGCCTTCGACCCAAGCAACATGCCACCTGGCATTGAGGCCAGTCCTGACAA AATGCTTCAGGGCCGCCTTTTTGCCTATCCTGACACTCACCGCCATCGCCTGGGACCCAATTATCTTCATATACCTGTGAACTGTCCCTA CCGTGCTCGAGTGGCCAACTACCAGCGTGACGGCCCGATGTGCATGCAGGACAATCAGGGTGGTGCTCCAAATTACTACCCCAACAGCTT TGGTGCTCCGGAACAACAGCCTTCTGCCCTGGAGCACAGCATCCAATATTCTGGAGAAGTGCGGAGATTCAACACTGCCAATGATGATAA CGTTACTCAGGTGCGGGCATTCTATGTGAACGTGCTGAATGAGGAACAGAGGAAACGTCTGTGTGAGAACATTGCCGGCCACCTGAAGGA TGCACAAATTTTCATCCAGAAGAAAGCGGTCAAGAACTTCACTGAGGTCCACCCTGACTACGGGAGCCACATCCAGGCTCTTCTGGACAA GTACAATGCTGAGAAGCCTAAGAATGCGATTCACACCTTTGTGCAGTCCGGATCTCACTTGGCGGCAAGGGAGAAGGCAAATCTGTGAGG CCGGGGCCCTGCACCTGTGCAGCGAAGCTTAGCGTTCATCCGTGTAACCCGCTCATCACTGGATGAAGATTCTCCTGTGCTAGATGTGCA AATGCAAGCTAGTGGCTTCAAAATAGAGAATCCCACTTTCTATAGCAGATTGTGTAACAATTTTAATGCTATTTCCCCAGGGGAAAATGA AGGTTAGGATTTAACAGTCATTTAAAAAAAAAATTTGTTTTGACGGATGATTGGATTATTCATTTAAAATGATTAGAAGGCAAGTTTCTA GCTAGAAATATGATTTTATTTGACAAAATTTGTTGAAATTATGTATGTTTACATATCACCTCATGGCCTATTATATTAAAATATGGCTAT AAATATATAAAAAGAAAAGATAAAGATGATCTACTCAGAAATTTTTATTTTTCTAAGGTTCTCATAGGAAAAGTACATTTAATACAGCAG TGTCATCAGAAGATAACTTGAGCACCGTCATGGCTTAATGTTTATTCCTGATAATAATTGATCAAATTCATTTTTTTCACTGGAGTTACA >In-frame_ENST00000442919_ENST00000241052_TCGA-EW-A1P7-01A_TLK1_chr2_171974249_-_CAT_chr11_34470739_length(amino acids)=592AA_start in transcript=469_stop in transcript=2247 MMSVQSSSGSLEGPPSWSQLSTSPTPGSAAAARSLLNHTPPSGRPREGAMDELHSLDPRRQELLEARFTGVASGSTGSTGSCSVGAKKAD VLTTGAGNPVGDKLNVITVGPRGPLLVQDVVFTDEMAHFDRERIPERVVHAKGAGAFGYFEVTHDITKYSKAKVFEHIGKKTPIAVRFST VAGESGSADTVRDPRGFAVKFYTEDGNWDLVGNNTPIFFIRDPILFPSFIHSQKRNPQTHLKDPDMVWDFWSLRPESLHQVSFLFSDRGI PDGHRHMNGYGSHTFKLVNANGEAVYCKFHYKTDQGIKNLSVEDAARLSQEDPDYGIRDLFNAIATGKYPSWTFYIQVMTFNQAETFPFN PFDLTKVWPHKDYPLIPVGKLVLNRNPVNYFAEVEQIAFDPSNMPPGIEASPDKMLQGRLFAYPDTHRHRLGPNYLHIPVNCPYRARVAN YQRDGPMCMQDNQGGAPNYYPNSFGAPEQQPSALEHSIQYSGEVRRFNTANDDNVTQVRAFYVNVLNEEQRKRLCENIAGHLKDAQIFIQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for TLK1-CAT |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TLK1-CAT |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TLK1-CAT |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | TLK1 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | TLK1 | C0027643 | Neoplasm Recurrence, Local | 1 | CTD_human |
Tgene | CAT | C0268419 | Acatalasia | 7 | CTD_human;GENOMICS_ENGLAND;ORPHANET |
Tgene | CAT | C0007621 | Neoplastic Cell Transformation | 6 | CTD_human |
Tgene | CAT | C0752048 | Hypocatalasemia | 5 | CTD_human |
Tgene | CAT | C2931868 | Catalase deficiency | 5 | CTD_human;ORPHANET |
Tgene | CAT | C2936847 | Acatalasemia Japanese type | 5 | CTD_human |
Tgene | CAT | C2936848 | Acatalasemia Swiss type | 5 | CTD_human |
Tgene | CAT | C0020538 | Hypertensive disease | 4 | CTD_human |
Tgene | CAT | C0035126 | Reperfusion Injury | 4 | CTD_human |
Tgene | CAT | C0038220 | Status Epilepticus | 4 | CTD_human |
Tgene | CAT | C0270823 | Petit mal status | 4 | CTD_human |
Tgene | CAT | C0311335 | Grand Mal Status Epilepticus | 4 | CTD_human |
Tgene | CAT | C0393734 | Complex Partial Status Epilepticus | 4 | CTD_human |
Tgene | CAT | C0751522 | Status Epilepticus, Subclinical | 4 | CTD_human |
Tgene | CAT | C0751523 | Non-Convulsive Status Epilepticus | 4 | CTD_human |
Tgene | CAT | C0751524 | Simple Partial Status Epilepticus | 4 | CTD_human |
Tgene | CAT | C0002152 | Alloxan Diabetes | 3 | CTD_human |
Tgene | CAT | C0011853 | Diabetes Mellitus, Experimental | 3 | CTD_human |
Tgene | CAT | C0022333 | Jacksonian Seizure | 3 | CTD_human |
Tgene | CAT | C0027627 | Neoplasm Metastasis | 3 | CTD_human |
Tgene | CAT | C0036572 | Seizures | 3 | CTD_human |
Tgene | CAT | C0038433 | Streptozotocin Diabetes | 3 | CTD_human |
Tgene | CAT | C0149958 | Complex partial seizures | 3 | CTD_human |
Tgene | CAT | C0234533 | Generalized seizures | 3 | CTD_human |
Tgene | CAT | C0234535 | Clonic Seizures | 3 | CTD_human |
Tgene | CAT | C0235874 | Disease Exacerbation | 3 | CTD_human |
Tgene | CAT | C0270824 | Visual seizure | 3 | CTD_human |
Tgene | CAT | C0270844 | Tonic Seizures | 3 | CTD_human |
Tgene | CAT | C0270846 | Epileptic drop attack | 3 | CTD_human |
Tgene | CAT | C0422850 | Seizures, Somatosensory | 3 | CTD_human |
Tgene | CAT | C0422852 | Seizures, Auditory | 3 | CTD_human |
Tgene | CAT | C0422853 | Olfactory seizure | 3 | CTD_human |
Tgene | CAT | C0422854 | Gustatory seizure | 3 | CTD_human |
Tgene | CAT | C0422855 | Vertiginous seizure | 3 | CTD_human |
Tgene | CAT | C0494475 | Tonic - clonic seizures | 3 | CTD_human |
Tgene | CAT | C0751056 | Non-epileptic convulsion | 3 | CTD_human |
Tgene | CAT | C0751110 | Single Seizure | 3 | CTD_human |
Tgene | CAT | C0751123 | Atonic Absence Seizures | 3 | CTD_human |
Tgene | CAT | C0751494 | Convulsive Seizures | 3 | CTD_human |
Tgene | CAT | C0751495 | Seizures, Focal | 3 | CTD_human |
Tgene | CAT | C0751496 | Seizures, Sensory | 3 | CTD_human |
Tgene | CAT | C3495874 | Nonepileptic Seizures | 3 | CTD_human |
Tgene | CAT | C4048158 | Convulsions | 3 | CTD_human |
Tgene | CAT | C4316903 | Absence Seizures | 3 | CTD_human |
Tgene | CAT | C4317109 | Epileptic Seizures | 3 | CTD_human |
Tgene | CAT | C4317123 | Myoclonic Seizures | 3 | CTD_human |
Tgene | CAT | C4505436 | Generalized Absence Seizures | 3 | CTD_human |
Tgene | CAT | C0000771 | Abnormalities, Drug-Induced | 2 | CTD_human |
Tgene | CAT | C0001973 | Alcoholic Intoxication, Chronic | 2 | PSYGENET |
Tgene | CAT | C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | 2 | CTD_human |
Tgene | CAT | C0019193 | Hepatitis, Toxic | 2 | CTD_human |
Tgene | CAT | C0022661 | Kidney Failure, Chronic | 2 | CTD_human |
Tgene | CAT | C0027540 | Necrosis | 2 | CTD_human |
Tgene | CAT | C0027626 | Neoplasm Invasiveness | 2 | CTD_human |
Tgene | CAT | C0860207 | Drug-Induced Liver Disease | 2 | CTD_human |
Tgene | CAT | C1262760 | Hepatitis, Drug-Induced | 2 | CTD_human |
Tgene | CAT | C1269683 | Major Depressive Disorder | 2 | CTD_human;PSYGENET |
Tgene | CAT | C3658290 | Drug-Induced Acute Liver Injury | 2 | CTD_human |
Tgene | CAT | C4277682 | Chemical and Drug Induced Liver Injury | 2 | CTD_human |
Tgene | CAT | C4279912 | Chemically-Induced Liver Toxicity | 2 | CTD_human |
Tgene | CAT | C0003493 | Aortic Diseases | 1 | CTD_human |
Tgene | CAT | C0003865 | Arthritis, Adjuvant-Induced | 1 | CTD_human |
Tgene | CAT | C0003873 | Rheumatoid Arthritis | 1 | CTD_human |
Tgene | CAT | C0004045 | Asphyxia Neonatorum | 1 | CTD_human |
Tgene | CAT | C0004096 | Asthma | 1 | CTD_human |
Tgene | CAT | C0004352 | Autistic Disorder | 1 | CTD_human |
Tgene | CAT | C0004943 | Behcet Syndrome | 1 | CTD_human |
Tgene | CAT | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Tgene | CAT | C0006826 | Malignant Neoplasms | 1 | CTD_human |
Tgene | CAT | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | CAT | C0007786 | Brain Ischemia | 1 | CTD_human |
Tgene | CAT | C0008370 | Cholestasis | 1 | CTD_human |
Tgene | CAT | C0008909 | Claustrophobia | 1 | CTD_human |
Tgene | CAT | C0011574 | Involutional Depression | 1 | CTD_human |
Tgene | CAT | C0011849 | Diabetes Mellitus | 1 | CTD_human |
Tgene | CAT | C0011854 | Diabetes Mellitus, Insulin-Dependent | 1 | CTD_human |
Tgene | CAT | C0011882 | Diabetic Neuropathies | 1 | CTD_human |
Tgene | CAT | C0013386 | Dyskinesia, Drug-Induced | 1 | CTD_human |
Tgene | CAT | C0013604 | Edema | 1 | CTD_human |
Tgene | CAT | C0015695 | Fatty Liver | 1 | CTD_human |
Tgene | CAT | C0015923 | Fetal Alcohol Syndrome | 1 | CTD_human |
Tgene | CAT | C0017638 | Glioma | 1 | CTD_human |
Tgene | CAT | C0018801 | Heart failure | 1 | CTD_human |
Tgene | CAT | C0018802 | Congestive heart failure | 1 | CTD_human |
Tgene | CAT | C0019158 | Hepatitis | 1 | CTD_human |
Tgene | CAT | C0019189 | Hepatitis, Chronic | 1 | CTD_human |
Tgene | CAT | C0020452 | Hyperemia | 1 | CTD_human |
Tgene | CAT | C0020550 | Hyperthyroidism | 1 | CTD_human |
Tgene | CAT | C0020649 | Hypotension | 1 | CTD_human |
Tgene | CAT | C0022593 | Keratosis | 1 | CTD_human |
Tgene | CAT | C0022594 | Keratosis Blennorrhagica | 1 | CTD_human |
Tgene | CAT | C0022650 | Kidney Calculi | 1 | CTD_human |
Tgene | CAT | C0023212 | Left-Sided Heart Failure | 1 | CTD_human |
Tgene | CAT | C0023891 | Liver Cirrhosis, Alcoholic | 1 | CTD_human |
Tgene | CAT | C0024141 | Lupus Erythematosus, Systemic | 1 | CTD_human |
Tgene | CAT | C0024796 | Marfan Syndrome | 1 | CTD_human |
Tgene | CAT | C0025500 | Mesothelioma | 1 | CTD_human |
Tgene | CAT | C0027051 | Myocardial Infarction | 1 | CTD_human |
Tgene | CAT | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
Tgene | CAT | C0027651 | Neoplasms | 1 | CTD_human |
Tgene | CAT | C0029458 | Osteoporosis, Postmenopausal | 1 | CTD_human |
Tgene | CAT | C0030246 | Pustulosis of Palms and Soles | 1 | CTD_human |
Tgene | CAT | C0032927 | Precancerous Conditions | 1 | CTD_human |
Tgene | CAT | C0033141 | Cardiomyopathies, Primary | 1 | CTD_human |
Tgene | CAT | C0033626 | Protein Deficiency | 1 | CTD_human |
Tgene | CAT | C0033860 | Psoriasis | 1 | CTD_human |
Tgene | CAT | C0034063 | Pulmonary Edema | 1 | CTD_human |
Tgene | CAT | C0034065 | Pulmonary Embolism | 1 | CTD_human |
Tgene | CAT | C0034069 | Pulmonary Fibrosis | 1 | CTD_human |
Tgene | CAT | C0036529 | Myocardial Diseases, Secondary | 1 | CTD_human |
Tgene | CAT | C0038358 | Gastric ulcer | 1 | CTD_human |
Tgene | CAT | C0041408 | Turner Syndrome | 1 | CTD_human |
Tgene | CAT | C0041696 | Unipolar Depression | 1 | PSYGENET |
Tgene | CAT | C0042484 | Venous Engorgement | 1 | CTD_human |
Tgene | CAT | C0079744 | Diffuse Large B-Cell Lymphoma | 1 | CTD_human |
Tgene | CAT | C0086501 | Keratoma | 1 | CTD_human |
Tgene | CAT | C0086692 | Benign Neoplasm | 1 | CTD_human |
Tgene | CAT | C0149519 | Chronic Persistent Hepatitis | 1 | CTD_human |
Tgene | CAT | C0151526 | Premature Birth | 1 | CTD_human |
Tgene | CAT | C0151603 | Anasarca | 1 | CTD_human |
Tgene | CAT | C0178824 | Reactive Hyperemia | 1 | CTD_human |
Tgene | CAT | C0205734 | Diabetes, Autoimmune | 1 | CTD_human |
Tgene | CAT | C0235527 | Heart Failure, Right-Sided | 1 | CTD_human |
Tgene | CAT | C0242380 | Libman-Sacks Disease | 1 | CTD_human |
Tgene | CAT | C0242488 | Acute Lung Injury | 1 | CTD_human |
Tgene | CAT | C0242526 | Gonadal Dysgenesis, 45,X | 1 | CTD_human |
Tgene | CAT | C0259783 | mixed gliomas | 1 | CTD_human |
Tgene | CAT | C0271673 | Symmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Tgene | CAT | C0271674 | Asymmetric Diabetic Proximal Motor Neuropathy | 1 | CTD_human |
Tgene | CAT | C0271678 | Diabetic Mononeuropathy | 1 | CTD_human |
Tgene | CAT | C0271680 | Diabetic Polyneuropathies | 1 | CTD_human |
Tgene | CAT | C0271685 | Diabetic Amyotrophy | 1 | CTD_human |
Tgene | CAT | C0271686 | Diabetic Autonomic Neuropathy | 1 | CTD_human |
Tgene | CAT | C0282313 | Condition, Preneoplastic | 1 | CTD_human |
Tgene | CAT | C0333233 | Active Hyperemia | 1 | CTD_human |
Tgene | CAT | C0333704 | Chromosome Breaks | 1 | CTD_human |
Tgene | CAT | C0342302 | Brittle diabetes | 1 | CTD_human |
Tgene | CAT | C0349231 | Phobic anxiety disorder | 1 | CTD_human |
Tgene | CAT | C0376628 | Chromosome Breakage | 1 | CTD_human |
Tgene | CAT | C0393835 | Diabetic Asymmetric Polyneuropathy | 1 | CTD_human |
Tgene | CAT | C0400966 | Non-alcoholic Fatty Liver Disease | 1 | CTD_human |
Tgene | CAT | C0520463 | Chronic active hepatitis | 1 | CTD_human |
Tgene | CAT | C0524611 | Cryptogenic Chronic Hepatitis | 1 | CTD_human |
Tgene | CAT | C0524702 | Pulmonary Thromboembolisms | 1 | CTD_human |
Tgene | CAT | C0555198 | Malignant Glioma | 1 | CTD_human |
Tgene | CAT | C0678222 | Breast Carcinoma | 1 | CTD_human |
Tgene | CAT | C0751074 | Diabetic Neuralgia | 1 | CTD_human |
Tgene | CAT | C0751088 | Dyskinesia, Medication-Induced | 1 | CTD_human |
Tgene | CAT | C0814154 | Alcohol Related Neurodevelopmental Disorder | 1 | CTD_human |
Tgene | CAT | C0878544 | Cardiomyopathies | 1 | CTD_human |
Tgene | CAT | C0917798 | Cerebral Ischemia | 1 | CTD_human |
Tgene | CAT | C0971858 | Arthritis, Collagen-Induced | 1 | CTD_human |
Tgene | CAT | C0993582 | Arthritis, Experimental | 1 | CTD_human |
Tgene | CAT | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Tgene | CAT | C1456865 | Ureteral Calculi | 1 | CTD_human |
Tgene | CAT | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Tgene | CAT | C1527168 | Bonnevie-Ullrich Syndrome | 1 | CTD_human |
Tgene | CAT | C1571983 | Involutional paraphrenia | 1 | CTD_human |
Tgene | CAT | C1571984 | Psychosis, Involutional | 1 | CTD_human |
Tgene | CAT | C1959583 | Myocardial Failure | 1 | CTD_human |
Tgene | CAT | C1961112 | Heart Decompensation | 1 | CTD_human |
Tgene | CAT | C2711227 | Steatohepatitis | 1 | CTD_human |
Tgene | CAT | C2985290 | Fetal Alcohol Spectrum Disorders | 1 | CTD_human |
Tgene | CAT | C3146244 | Alcohol Related Birth Defect | 1 | CTD_human |
Tgene | CAT | C3241937 | Nonalcoholic Steatohepatitis | 1 | CTD_human |
Tgene | CAT | C3661483 | Partial Fetal Alcohol Syndrome | 1 | CTD_human |
Tgene | CAT | C3714618 | Primary Hyperthyroidism | 1 | CTD_human |
Tgene | CAT | C3837958 | Diabetes Mellitus, Ketosis-Prone | 1 | CTD_human |
Tgene | CAT | C4554117 | Diabetes Mellitus, Sudden-Onset | 1 | CTD_human |
Tgene | CAT | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
Tgene | CAT | C4721507 | Alveolitis, Fibrosing | 1 | CTD_human |
Tgene | CAT | C4721845 | Marfan Syndrome, Type I | 1 | CTD_human |